Joint with: Obesity Causes and Consequences
Cardiometabolic Diseases: The Role of Ethnic Diversity in Precision Medicine

Feb 04–07, 2024 | Fairmont Hotel Vancouver, Vancouver, BC, Canada
Scientific Organizers: Paul W. Franks, Ewan Pearson and Karin Conde-Knape

  In Person
  On Demand

Feb 04–07, 2024 | Fairmont Hotel Vancouver, Vancouver, BC, Canada
Scientific Organizers: Paul W. Franks, Ewan Pearson and Karin Conde-Knape

Important Deadlines
Early Registration Deadline: Dec. 5, 2023
Scholarship Deadline: Nov. 30, 2023
Short Talk Abstract Deadline: Deadlines not yet available for this meeting.
Poster Abstract Deadline: Dec. 5, 2023
Meeting Summary

# Metabolism and Cardiovascular

Obesity prevalence has tripled over the past four decades. Together with its wide range of comorbidities, it accounts for a large proportion of the worldwide non-communicable disease burden. One of the critical barriers in effectively tackling obesity is the prevailing societal perception of it being a simple energy balance problem, one that this meeting seeks to dismantle. In truth there are a myriad of causes that lead to obesity, and as a result a wide array of consequences that emerge. Moreover time is rapidly changing in the field of obesity with the emergence of new and innovative therapies. While the value of model organisms is recognized in the field, this program was designed to focus on the model that matters most: humans.

The goals of this meeting is to explore the latest in:

(1) causes of obesity, including genetics, environmental impacts, and hypothalamic dysfunction;

(2) how the heterogeneity of obesity impacts upon its precision management;

(3) metabolic consequences of obesity, including Type 2 Diabetes, dyslipidemia, as well as cardiovascular, liver and renal disease

(4) innovation in treatment and new molecular targets.

This conference will be paired with another Keystone Symposia conference entitled Cardiometabolic Diseases: The Role of Ethnic Diversity in Precision Medicine, where shared scientific sessions will explore cross connectivity of genetics and precision obesity management. These joint conferences will also bring together an interdisciplinary group of investigators with different focus areas within the field, ranging from ‘big data’ to detailed mechanistic studies. Participants of both conferences will also have an opportunity to network at shared meals and poster sessions. This unique environment will lead to new scientific collaborations and the implementation of precision medicine approaches directed at better understanding and treating cardiometabolic disease.

Co-Organizer, and Scientific Director at Novo Nordisk Foundation, Paul W. Franks, talks about why you should attend this meeting in the video below:

Unique Career Development Opportunities

This meeting will feature a Career Roundtable where trainees and early-career investigators will have the opportunity to interact with field leaders from across academic and industry sectors for essential career development advice and networking opportunities. Find out more about Career Roundtables here: https://www.keystonesymposia.org/diversity/career-development-initiatives

Federal Funding provided by the National Institutes of Health: 

Funding for this conference was made possible (in part) by 1 R13 DK138735-01 from NIDDK. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention by trade names, commercial practices, or organizations imply endorsement by the U.S. Government.

To access the NIH Safe Environment Policy, please click here.

KEYSTONE SYMPOSIA THANKS OUR GIFT-IN-KIND MEDIA SPONSORS

Subscribe for Updates